MedPath
HSA Approval

SITAVITAE FILM-COATED TABLETS 100 MG

SIN17162P

SITAVITAE FILM-COATED TABLETS 100 MG

SITAVITAE FILM-COATED TABLETS 100 MG

January 8, 2025

NOVEM HEALTHCARE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM HEALTHCARE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

A10BH01

Manufacturer Information

NOVEM HEALTHCARE PTE LTD

SAG Manufacturing S.L.U.

Active Ingredients

Sitagliptin HCl monohydrate eqv sitagliptin

100 mg

Sitagliptin

Documents

Package Inserts

Sitavitae_PI.pdf

Approved: February 27, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SITAVITAE FILM-COATED TABLETS 100 MG - HSA Approval | MedPath